Clinical Trial Update: Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP) [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating toripalimab in combination with docetaxel and carboplatin for localized triple-negative breast cancer has completed enrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer, Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED